Article Text

PDF
Featured correspondence
The comparison of biomarkers with clinically determined risk
  1. Jin-Ho Choi1,2,
  2. Eun-Seok Jeon1
  1. 1 Department of Medicine, Cardiovascular Imaging Center, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  2. 2Department of Emergency Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  1. Correspondence to Jin-Ho Choi, Irwon-Dong 50 Gangnam-Ku, Seoul 135-710, Republic of Korea; choijinh{at}skku.edu

Statistics from Altmetric.com

The Authors' reply: We thank Dr Adnan Nadir for thoughtful comments on our study.1 We agree with the author that not only the additive role of biomarkers (represented as N-terminal prohormone brain natriuretic peptide, NT-proBNP, or C reactive protein, CRP) …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles